论文部分内容阅读
Human intercellular adhesion molecule-1 (ICAM-1) is an attractive target for development of new therapies to prevent rhinovirus infection by blocking virus-receptor binding.By an integrated approach, we are discovering and developing such antibodies with high affinity for therapeutic purposes.